IP Library Patent Application 15056796
Patent Application
App. No. 15/056,796

METHODS FOR CLONING AND MANIPULATING GENOMES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/056,796
Abstract

Compositions and methods are disclosed herein for cloning a donor genome in a heterologous host cell. In one embodiment, the donor genome can be further modified within a host cell. Modified or unmodified genomes can be further isolated from the host cell and transferred to a recipient cell. Methods disclosed herein can be used to alter donor genomes from intractable donor cells in more tractable host cells.

Claims (38)

1 . A method for seamlessly introducing a modification in a target nucleic acid molecule present in a host cell, comprising:

a. introducing a mutagenesis construct and a host vector into the host cell whereby the host vector recombines with the mutagenesis construct in the host cell,

wherein the mutagenesis construct contains

a first portion of homology to a 5′ portion of the target nucleic acid molecule upstream of the modification;

an endonuclease recognition site;

a promoter;

a gene encoding the endonuclease; and

a selectable marker;

a second repeat portion of homology that is homologous to a sequence of the target nucleic acid molecule upstream of a target region on the target nucleic acid molecule;

a third portion of homology that is homologous to a 3′ portion of the target region on the target nucleic acid molecule downstream of the modification; and

b. incubating the cells under conditions

i. whereby recombination occurs between the first portion of homology and the upstream or downstream portion, thereby seamlessly removing a portion of the construct,

ii. that promote one or more double-strand break cleavages in the target nucleic acid molecule near the target region containing the construct,

whereby a modification is seamlessly introduced into the target nucleic acid molecule.

2 . The method of claim 1 wherein the endonuclease recognition site is an I-SceI recognition site.

3 . The method of claim 1 wherein the promoter is a GAL-1 promoter.

4 . The method of claim 1 wherein the selectable marker is URA3.

5 . The method of claim 1 wherein the endonuclease recognition site is an I-SceI recognition site, the promoter is a GAL-1 promoter, and the selectable marker is URA3.

6 . The method of claim 1 wherein the portion of the construct that is removed is the selectable marker.

7 . The method of claim 6 wherein the endonuclease is inducibly expressed.

8 . The method of claim 7 wherein the double strand break cleavage is generated by the inducibly expressed endonuclease.

9 . The method of claim 8 further comprising the introduction of a sequence generating tandem repeat regions that flank the target region or portion thereof on the target nucleic acid molecule.

10 . The method of claim 9 wherein the tandem repeat regions that flank the target region or portion thereof flank the selectable marker.

11 . The method of claim 1 wherein the host cell is a yeast cell.

12 . The method of claim 11 wherein the yeast cell is Saccharomyces cerevisiae or Saccharomyces pombe.

13 . The method of claim 11 wherein the target nucleic acid molecule is a bacterial, cyanobacterial, or microalgal donor genome.

14 . The method of claim 13 wherein the target nucleic acid molecule is a bacterial genome.

15 . The method of claim 14 wherein the target nucleic acid molecule is a Mycoplasma genome.

16 . The method of claim 11 wherein the modification is a homologous recombination.

17 . The method of claim 15 wherein the modification is a homologous recombination.

18 . The method of claim 16 wherein the homologous recombination is selected from the group consisting of: a point mutation, a substitution, an insertion, and the modification of a nucleotide.

19 . The method of claim 17 wherein the homologous recombination is selected from the group consisting of: a point mutation, a substitution, an insertion, and the modification of a nucleotide.

20 . The method of claim 1 wherein:

a. the host cell is a yeast of the genus Saccharomyces;

b. the endonuclease recognition site is a I-SceI recognition site;

c. the promoter is a GAL-1 promoter;

d. the selectable marker is URA3; and

e. the endonuclease is inducibly expressed and the double strand break cleavage is generated by the inducibly expressed endonuclease.

Assignments (4)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066372/0745 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066372/0761 →